Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Small Molecule API Market: Notable Developments & Geographical Outlook

Published by mark itwired

Posted on September 9, 2021

Featured image for article about Research Reports

Future Market Insights’ global small molecule active pharmaceutical ingredient (API) market report forecasts a prolific nudge through 2021, as increasing demand of high potency drugs and increasing chronic diseases boosts the market demand. Rising cancer cases and increasing demand for effective diagnosis and R&D for oncology procedures is accelerating the growth of small molecule API market.

Furthermore, rising government reimbursement policies and funding to develop small molecule oncology drugs is spurring the growth of market. Rapid development in technologies for long-term delivery of medication in molecule type is aiding the growth for small molecule API market. Driven by these factors, the market is poised to expand at the rate of 5% CAGR through 2021.

For instance, chronic disease such as diabetes, asthma, cancer, are significantly rising across the globe. According to the report of International Diabetes Federation, around 463 million people in 2019 were diagnosed with diabetes and new cancer cases are expected to grow by 23.6 million by 2030. Hence, rising incidence of various chronic disease are providing growth opportunities for manufacturing companies.

“Increasing research on small molecule APIs and novel biologics is expected to drive the market demand,” remarks the FMI analyst.

Request a report sample with 255 pages to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-4591

Key Takeaways

Standard API will hold the maximum share of over 79.6% through 2021
Oncology segmented is expected to be the lucrative segment, accounting for 26.6% market share
Commercial application account for greater grater sales of small molecule API
China is estimated to remain one of the most lucrative market for small molecule, exhibiting growth of 5.5% CAGR
India is expected to emerge as a lucrative market backed by increasing manufacturing in pharmaceutical industry
Germany to retain its dominance in European small molecule API market, accounting for over 30% sales

Prominent Drivers

Technological advancements in API manufacturing and growing importance of generics are key factors driving market demand
Growing adoption of AI-based tools for drug discovery is expected to propel the market growth
Investment in small molecule API drug discovery from pharmaceutical companies is likely to improve the demand
Growing demand for newly developed small molecule drugs in manufacturing industry is expected to improve the demand

Key Restraints

Increasing penetration of counterfeit drugs is likely to restrict the growth of small molecule API market

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/4591

The post Small Molecule API Market: Notable Developments & Geographical Outlook first appeared on Market Research Blog.